About Align Technology (NASDAQ:ALGN)
Align Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases. It also provides Invisalign Express (10 and 5) and Invisalign Lite/i7 treatments for orthodontic cases, non-comprehensive treatment relapse cases, or straightening prior to restorative or cosmetic treatments; Invisalign Go, a solution for general practitioner dentists (GPs) to identify and treat patients with mild malocclusion; SmileDirectClub aligners for minor tooth movement; custom clear aligner retainers used to maintain tooth position and correct minor relapse; and SmartTrack, a custom-engineered material that delivers force for orthodontic tooth movements. The company's Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; and Restorative software for iTero, a software for GPs, prosthodontists, periodontists, and oral surgeons. It also provides Orthodontic software for iTero, a software for orthodontists for digital records storage, orthodontic diagnosis, Invisalign digital impression submission, and for the fabrication of printed models and retainers; CAD/CAM services, such as iTero Models and Dies, OrthoCAD iCast, and OrthoCAD iRecord; and Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner, as well as third party scanners and digital scans for Invisalign treatment submission. The company was founded in 1997 and is headquartered in San Jose, California.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:ALGN
CUSIP01625510
Phone408-738-1500
Debt
Debt-to-Equity RatioN/A
Current Ratio2.32%
Quick Ratio2.26%
Price-To-Earnings
Trailing P/E Ratio63.14
Forward P/E Ratio54.22
P/E Growth1.87
Sales & Book Value
Annual Sales$1.47 billion
Price / Sales13.36
Cash Flow$4.4091 per share
Price / Cash55.71
Book Value$14.35 per share
Price / Book17.12
Profitability
EPS (Most Recent Fiscal Year)$3.89
Net Income$231.41 million
Net Margins15.71%
Return on Equity28.55%
Return on Assets19.61%
Miscellaneous
Employees8,715
Outstanding Shares80,140,000
Align Technology (NASDAQ:ALGN) Frequently Asked Questions
What is Align Technology's stock symbol?
Align Technology trades on the NASDAQ under the ticker symbol "ALGN."
How were Align Technology's earnings last quarter?
Align Technology (NASDAQ:ALGN) released its quarterly earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $0.88 by $0.29. The medical equipment provider had revenue of $436.92 million for the quarter, compared to the consensus estimate of $408.27 million. Align Technology had a net margin of 15.71% and a return on equity of 28.55%. Align Technology's revenue was up 40.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.59 EPS. View Align Technology's Earnings History.
When is Align Technology's next earnings date?
What guidance has Align Technology issued on next quarter's earnings?
Align Technology issued an update on its second quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share guidance of $1.02-1.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.03. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $452.20 million.
What price target have analysts set for ALGN?
14 Wall Street analysts have issued 12 month price targets for Align Technology's stock. Their forecasts range from $150.00 to $305.00. On average, they anticipate Align Technology's share price to reach $254.1429 in the next twelve months. View Analyst Ratings for Align Technology.
What are Wall Street analysts saying about Align Technology stock?
Here are some recent quotes from research analysts about Align Technology stock:
- 1. According to Zacks Investment Research, "Over the past six months, Align Technology has been outperforming its broader industry. The company has been delivering strong performance over the past few quarters. We are encouraged by Align Technology’s solid Invisalign Technology prospects and growth in North America and internationally, particularly in the Asia-Pacific region. We are also upbeat about the company making an extension to its Invisalign clear aligner range with the latest launch of Vivera Retainers with Precision Bite Ramps. Further, the latest addition of Invisalign First clear aligners for treatment of younger patients with early mixed dentition also buoys optimism. On the flip side, adverse foreign currency fluctuation is a concern. Moreover, tough competition, rising operating costs and macroeconomic headwinds continue to weigh on the stock." (4/20/2018)
- 2. Leerink Swann analysts commented, "healthy" (6/26/2017)
Who are some of Align Technology's key competitors?
Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Coloplast (CLPBY), William Demant (WILYY), STERIS (STE), Mine Safety Appliances (MSA), Inogen (INGN), Halyard Health (HYH), Wright Medical Group (WMGI), Consort Medical (CSRMY), Invacare (IVC), RTI Surgical (RTIX) and Sientra (SIEN).
Who are Align Technology's key executives?
Align Technology's management team includes the folowing people:
- Mr. Joseph M. Hogan, Pres, CEO & Director (Age 61)
- Mr. John F. Morici, CFO & Sr. VP of Global Fin. (Age 51)
- Mr. Emory M. Wright, Sr. VP of Global Operations (Age 48)
- Mr. Zelko Relic, CTO and Sr. VP of Global R&D (Age 53)
- Mr. Raphael S. Pascaud, Chief Marketing Portfolio & Bus. Devel. Officer and Sr. VP of iTero Scanner & Services (Age 46)
Has Align Technology been receiving favorable news coverage?
Media headlines about ALGN stock have trended somewhat positive this week, according to Accern. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Align Technology earned a coverage optimism score of 0.12 on Accern's scale. They also gave media coverage about the medical equipment provider an impact score of 45.29 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of Align Technology?
Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Align Technology's stock price today?
One share of ALGN stock can currently be purchased for approximately $245.63.
How big of a company is Align Technology?
Align Technology has a market capitalization of $19.81 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.
How can I contact Align Technology?
Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-738-1500 or via email at [email protected]
MarketBeat Community Rating for Align Technology (ALGN)
MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe ALGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Align Technology (NASDAQ:ALGN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
14 Wall Street analysts have issued ratings and price targets for Align Technology in the last 12 months. Their average twelve-month price target is $254.1429, suggesting that the stock has a possible upside of 3.47%. The high price target for ALGN is $305.00 and the low price target for ALGN is $150.00. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.79 | 2.85 | 2.83 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $254.1429 | $256.3846 | $237.00 | $213.20 |
| Price Target Upside: | 3.47% upside | 2.48% downside | 12.45% downside | 5.03% upside |
Align Technology (NASDAQ:ALGN) Consensus Price Target History
Align Technology (NASDAQ:ALGN) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
Align Technology (NASDAQ:ALGN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Align Technology (NASDAQ ALGN) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.40%
Institutional Ownership Percentage: 80.28%
Align Technology (NASDAQ ALGN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/13/2018 | Joseph M Hogan | Insider | Buy | 1,500 | $233.63 | $350,445.00 | 42,984 |  |
| 2/2/2018 | Emory Wright | VP | Sell | 45,780 | $260.08 | $11,906,462.40 | 29,957 | |
| 11/30/2017 | Joseph Lacob | Director | Sell | 29,724 | $260.91 | $7,755,288.84 | | |
| 11/28/2017 | Emory Wright | VP | Sell | 5,025 | $263.68 | $1,324,992.00 | 80,762 | |
| 11/24/2017 | John Morici | CFO | Sell | 1,500 | $255.00 | $382,500.00 | 1,544 | |
| 11/13/2017 | Julie Tay | VP | Sell | 3,500 | $253.00 | $885,500.00 | 12,213 | |
| 11/3/2017 | Raphael Pascaud | CMO | Sell | 5,400 | $241.88 | $1,306,152.00 | 22,228 | |
| 10/31/2017 | Greg J Santora | Director | Sell | 7,700 | $238.95 | $1,839,915.00 | | |
| 5/31/2017 | Joseph Lacob | Director | Sell | 50,000 | $144.98 | $7,249,000.00 | | |
| 5/30/2017 | Joseph Lacob | Director | Sell | 3,874 | $143.96 | $557,701.04 | | |
| 5/30/2017 | Sreelakshmi Kolli | VP | Sell | 1,000 | $144.00 | $144,000.00 | 23,785 | |
| 2/28/2017 | Joseph Lacob | Director | Sell | 50,000 | $102.67 | $5,133,500.00 | | |
| 2/24/2017 | Christopher C Puco | VP | Sell | 24,353 | $101.88 | $2,481,083.64 | 19,691 | |
| 2/22/2017 | Thomas M Prescott | Director | Sell | 66,528 | $101.12 | $6,727,311.36 | 272,253 | |
| 2/15/2017 | Andrea Lynn Saia | Director | Sell | 4,000 | $99.68 | $398,720.00 | 14,133 | |
| 2/3/2017 | C Raymond Larkin Jr | Director | Sell | 15,000 | $94.71 | $1,420,650.00 | 92,012 | |
| 11/29/2016 | Jennifer Olson | VP | Sell | 3,662 | $95.44 | $349,501.28 | 8,145 | |
| 11/29/2016 | Warren S Thaler | Director | Sell | 8,500 | $95.57 | $812,345.00 | 42,400 | |
| 11/18/2016 | David L White | CFO | Sell | 11,152 | $95.53 | $1,065,350.56 | 9,473 | |
| 11/14/2016 | Thomas M Prescott | Director | Sell | 33,125 | $90.60 | $3,001,125.00 | 124,378 | |
| 8/29/2016 | Jennifer Olson | VP | Sell | 799 | $93.30 | $74,546.70 | 4,483 | |
| 8/15/2016 | Zelko Relic | VP | Sell | 13,577 | $95.91 | $1,302,170.07 | 1,375 | |
| 8/9/2016 | Julie Tay | VP | Sell | 3,000 | $92.60 | $277,800.00 | 3,104 | |
| 5/23/2016 | George J Morrow | Director | Sell | 50,000 | $77.72 | $3,886,000.00 | 56,400 | |
| 5/16/2016 | Raphael Pascaud | VP | Sell | 3,000 | $77.00 | $231,000.00 | 5,887 | |
| 5/10/2016 | Julie Tay | VP | Sell | 1,250 | $77.00 | $96,250.00 | 6,104 | |
| 5/5/2016 | C Raymond Larkin Jr | Director | Sell | 15,000 | $74.36 | $1,115,400.00 | 85,260 | |
| 5/5/2016 | Roger E George | VP | Sell | 27,311 | $75.00 | $2,048,325.00 | 27,986 | |
| 5/3/2016 | Julie Tay | VP | Sell | 1,754 | $75.00 | $131,550.00 | 7,354 | |
| 5/3/2016 | Thomas M Prescott | Director | Sell | 64,773 | $74.54 | $4,828,179.42 | 111,253 | |
| 2/25/2016 | Christopher C Puco | VP | Sell | 11,413 | $63.51 | $724,839.63 | 4,528 | |
| 2/23/2016 | Timothy A. Mack | VP | Sell | 28,384 | $63.25 | $1,795,288.00 | | |
| 2/22/2016 | Christopher C. Puco | VP | Sell | 6,278 | $64.01 | $401,854.78 | | |
| 2/4/2016 | Greg J Santora | Director | Sell | 9,000 | $67.28 | $605,520.00 | | |
| 1/5/2016 | David C Nagel | Director | Sell | 1,100 | $64.64 | $71,104.00 | 24,700 | |
| 12/14/2015 | David C Nagel | Director | Sell | 1,100 | $65.20 | $71,720.00 | 25,800 | |
| 11/2/2015 | Julie Tay | VP | Sell | 1,500 | $66.67 | $100,005.00 | 500 | |
| 10/30/2015 | Emory Wright | VP | Sell | 25,272 | $65.04 | $1,643,690.88 | 29,719 | |
| 10/28/2015 | Jennifer Erfurth | VP | Sell | 6,198 | $66.04 | $409,315.92 | 686 | |
| 10/27/2015 | David L. White | CFO | Sell | 8,426 | $66.85 | $563,278.10 | 5,636 | |
| 10/27/2015 | Greg J. Santora | Director | Sell | 20,000 | $66.95 | $1,339,000.00 | 35,900 | |
| 8/25/2015 | Andrea Lynn Saia | Director | Sell | 3,567 | $55.10 | $196,541.70 | 9,067 | |
| 8/20/2015 | Warren S. Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | 53,100 | |
| 8/17/2015 | Thomas M Prescott | Director | Sell | 40,000 | $60.50 | $2,420,000.00 | | |
| 5/15/2015 | Jennifer Erfurth | VP | Sell | 2,400 | $59.27 | $142,248.00 | | |
| 5/7/2015 | C Raymond Larkin Jr | Director | Sell | 15,000 | $59.03 | $885,450.00 | | |
| 5/6/2015 | Warren S Thaler | Director | Sell | 7,000 | $58.75 | $411,250.00 | | |
| 5/5/2015 | David L White | CFO | Sell | 1,899 | $59.37 | $112,743.63 | | |
| 5/5/2015 | John Patrick Graham | CMO | Sell | 1,139 | $60.37 | $68,761.43 | | |
| 5/5/2015 | Timothy A Mack | VP | Sell | 28,280 | $59.47 | $1,681,811.60 | | |
| 5/1/2015 | Roger E George | VP | Sell | 23,248 | $58.69 | $1,364,425.12 | | |
| 2/26/2015 | Raphael Pascaud | VP | Sell | 6,500 | $56.40 | $366,600.00 | | |
| 2/24/2015 | Christopher C Puco | VP | Sell | 11,982 | $56.40 | $675,784.80 | | |
| 11/4/2014 | Timothy A Mack | VP | Sell | 9,375 | $52.17 | $489,093.75 | | |
| 10/28/2014 | C Raymond Larkin Jr | Director | Sell | 15,000 | $51.54 | $773,100.00 | | |
| 10/28/2014 | Jennifer Erfurth | VP | Sell | 6,242 | $52.25 | $326,144.50 | | |
| 8/27/2014 | Roger E George | VP | Sell | 10,875 | $55.85 | $607,368.75 | | |
| 8/21/2014 | David L White | CFO | Sell | 4,600 | $54.42 | $250,332.00 | | |
| 8/21/2014 | John Patrick Graham | CMO | Sell | 7,046 | $54.41 | $383,372.86 | | |
| 8/19/2014 | Thomas M Prescott | CEO | Sell | 14,896 | $55.07 | $820,322.72 | | |
| 5/29/2014 | Timothy A Mack | VP | Sell | 16,333 | $55.06 | $899,294.98 | | |
| 5/1/2014 | Raphael Pascaud | VP | Sell | 2,000 | $50.79 | $101,580.00 | 105 | |
| 2/25/2014 | Christopher Puco | VP | Sell | 4,462 | $54.09 | $241,349.58 | | |
| 2/24/2014 | Roger George | VP | Sell | 19,474 | $54.23 | $1,056,075.02 | | |
| 2/11/2014 | Jennifer Erfurth | VP | Sell | 3,144 | $55.34 | $173,988.96 | | |
| 2/7/2014 | Thomas Prescott | CEO | Sell | 236,979 | $54.64 | $12,948,532.56 | 171,995 | |
| 2/4/2014 | Timothy Mack | VP | Sell | 12,761 | $54.73 | $698,409.53 | 67 | |
| 2/4/2014 | Warren Thaler | Director | Sell | 18,000 | $54.75 | $985,500.00 | 33,900 | |
| 10/31/2013 | Jennifer Erfurth | VP | Sell | 3,242 | $56.97 | $184,696.74 | | |
| 10/30/2013 | Richard M.L. Twomey | VP | Sell | 4,010 | $57.05 | $228,770.50 | | |
| 10/30/2013 | Thomas M Prescott | CEO | Sell | 188,176 | $56.88 | $10,703,450.88 | | |
| 10/30/2013 | Warren S Thaler | Director | Sell | 35,250 | $56.55 | $1,993,387.50 | | |
| 10/22/2013 | George J Morrow | Director | Sell | 75,000 | $57.27 | $4,295,250.00 | | |
| 10/22/2013 | Thomas M Prescott | CEO | Sell | 74,513 | $58.00 | $4,321,754.00 | | |
| 8/29/2013 | Richard M.L. Twomey | VP | Sell | 2,135 | $43.76 | $93,427.60 | 4,272 | |
| 8/29/2013 | Timothy Mack | SVP | Sell | 18,477 | $43.32 | $800,423.64 | 3,386 | |
| 8/9/2013 | Joseph Lacob | Director | Sell | 8,000 | $43.85 | $350,800.00 | | |
| 8/1/2013 | Greg Santora | Director | Sell | 16,000 | $43.79 | $700,640.00 | 22,700 | |
| 7/30/2013 | Warren S Thaler | Director | Sell | 10,000 | $42.24 | $422,400.00 | | |
| 7/25/2013 | Roger E George | VP | Sell | 26,252 | $43.55 | $1,143,274.60 | | |
| 7/24/2013 | Richard M.L. Twomey | VP | Sell | 4,532 | $43.42 | $196,779.44 | | |
| 5/31/2013 | Joseph Lacob | Director | Sell | 49,998 | $36.16 | $1,807,927.68 | | |
| 5/15/2013 | Richard M.L. Twomey | VP | Sell | 1,875 | $36.10 | $67,687.50 | | |
| 2/4/2013 | Len Hedge | SVP | Sell | 100,000 | $31.38 | $3,138,000.00 | | |
| 11/12/2012 | Dan Scott Ellis | VP | Sell | 18,815 | $26.52 | $498,973.80 | | |
| 8/9/2012 | Joseph Lacob | Director | Sell | 300,000 | $34.97 | $10,491,000.00 | | |
(Data available from 1/1/2013 forward)
Align Technology (NASDAQ ALGN) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Align Technology (ALGN) Issues Quarterly Earnings Results
www.americanbankingnews.com - April 25 at 9:20 PM |
| Align Technology (ALGN) Issues Q2 Earnings Guidance
www.americanbankingnews.com - April 25 at 6:28 PM |
 | Medical Product Stock Earnings Roster for Apr 25: LH & More
finance.yahoo.com - April 24 at 10:19 AM |
| Should You Buy Align Technology (ALGN) Ahead of Earnings?
finance.yahoo.com - April 24 at 10:19 AM |
| Morgan Stanley Downgraded Align Technology before 1Q18 Results
finance.yahoo.com - April 24 at 10:19 AM |
 | Orthodontic Supplies Market to Hit 8.9% CAGR to 2023, Led by Align Technology, Inc. (US), 3M Company (US), and Danaher Corporation (US)
www.prnewswire.com - April 23 at 11:32 AM |
| Align Technology (ALGN) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 20 at 1:19 PM |
| Berenberg Bank Initiates Coverage on Align Technology (ALGN)
www.americanbankingnews.com - April 20 at 9:28 AM |
 | Nasdaq 100 Movers: ALGN, SHPG
www.nasdaq.com - April 19 at 3:46 PM |
 | UPDATE: Morgan Stanley Downgrades Align Technology (ALGN) to Equalweight Citing Valuation & Slowing Lead Indicators
www.streetinsider.com - April 19 at 3:46 PM |
| Align Technology Inc (NASDAQ:ALGN): What Does The Future Look Like?
finance.yahoo.com - April 19 at 3:46 PM |
| Align Tech Faces Slowing Growth, Potential Headwinds, Morgan Stanley Says In Downgrade
finance.yahoo.com - April 19 at 3:46 PM |
| Why Align Technology Inc. is Down Over 8.5%
finance.yahoo.com - April 19 at 3:46 PM |
| Can Steady Overall Growth Drive Align's (ALGN) Q1 Earnings?
finance.yahoo.com - April 19 at 10:30 AM |
 | Align Tech down 3% premarket after MS downgrade
seekingalpha.com - April 19 at 10:30 AM |
| Can Steady Overall Growth Drive Align's (ALGN) Q1 Earnings?
finance.yahoo.com - April 19 at 10:30 AM |
| Align Technology's (ALGN) Equal Weight Rating Reaffirmed at Morgan Stanley
www.americanbankingnews.com - April 19 at 9:03 AM |
| Align Technology (ALGN) Rating Lowered to Equal Weight at Morgan Stanley
www.americanbankingnews.com - April 18 at 5:18 PM |
| Align Technology (ALGN) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 2:12 AM |
| Align Technology (ALGN) Expected to Post Quarterly Sales of $408.25 Million
www.americanbankingnews.com - April 17 at 4:45 AM |
| Analysts Expect Align Technology (ALGN) Will Post Earnings of $0.98 Per Share
www.americanbankingnews.com - April 15 at 3:06 AM |
| Should You Buy Align Technology Inc (NASDAQ:ALGN) Now?
finance.yahoo.com - April 12 at 3:48 PM |
| 9 Stocks Fueled By High-Octane Sales Growth
finance.yahoo.com - April 10 at 3:43 PM |
| What Wall Street Analysts Recommend for Dentsply Sirona
finance.yahoo.com - April 9 at 10:45 AM |
| Zacks.com featured highlights include: Amazon.com, Align, Axon Enterprise, Antero and Jones Lang
finance.yahoo.com - April 9 at 10:45 AM |
| Align Technology (ALGN) vs. ReWalk Robotics (RWLK) Head to Head Review
www.americanbankingnews.com - April 8 at 9:32 PM |
| Company News For April 6, 2018
finance.yahoo.com - April 6 at 11:08 AM |
| Get Earnings Surprise From 5 Top Stocks & Beat Market Blues
finance.yahoo.com - April 6 at 11:08 AM |
| Align Unveils Vivera Retainers for Deep Bite Correction
finance.yahoo.com - April 5 at 3:45 PM |
| Align Technology Broadens Invisalign Suite, Extends Reach
finance.yahoo.com - April 5 at 3:45 PM |
| Align Tech debuts new products
seekingalpha.com - April 5 at 8:22 AM |
| Align Technology Expands Invisalign® Product Portfolio With New Options and Greater Flexibility to Treat a Broader Range of Patients
finance.yahoo.com - April 4 at 5:36 PM |
| Align Technology Extends Invisalign G5 Precision Bite Ramps to Vivera Retainers
finance.yahoo.com - April 4 at 5:36 PM |
| Align Technology Introduces Invisalign Clear Aligners for Phase 1 Treatment of Younger Patients With Early Mixed Dentition
finance.yahoo.com - April 4 at 5:36 PM |
| Align Technology (ALGN) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 4 at 1:21 PM |
| Align Technology (ALGN) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - April 4 at 11:15 AM |
| Contrasting MSA Safety (MSA) & Align Technology (ALGN)
www.americanbankingnews.com - April 4 at 3:08 AM |
| Align Technology (ALGN) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 4 at 1:22 AM |
| Align Technology to Announce First Quarter 2018 Results on April 25, 2018
finance.yahoo.com - April 2 at 3:46 PM |
| Analysts Expect Align Technology (ALGN) Will Post Quarterly Sales of $408.25 Million
www.americanbankingnews.com - March 31 at 4:14 AM |
| Zacks: Brokerages Expect Align Technology, Inc. (ALGN) to Announce $0.98 Earnings Per Share
www.americanbankingnews.com - March 29 at 10:19 AM |
| Dental Implant & Prosthetic Boom Puts Spotlight on 3 Stocks
finance.yahoo.com - March 27 at 3:51 PM |
| Align Technology (ALGN) PT Raised to $295.00
www.americanbankingnews.com - March 26 at 4:18 PM |
| Align Technology (ALGN) Raised to "Strong-Buy" at Vetr
www.americanbankingnews.com - March 26 at 9:55 AM |
| Align Technology (ALGN) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - March 26 at 9:13 AM |
| Reading Dentsply Sirona’s Guidance for 2018
finance.yahoo.com - March 21 at 11:21 AM |
 | 12 Growth Stocks That Will Win Long Term: Goldman - Investopedia (blog)
www.investopedia.com - March 20 at 3:51 PM |
 | Opinion: Are Facebook, Amazon and Google bad for America? - MarketWatch
www.marketwatch.com - March 20 at 3:51 PM |
| Why Is Dentsply Sirona So Confident That It Can Gain Market Share?
finance.yahoo.com - March 20 at 3:51 PM |
| Align Technology (ALGN) Upgraded by Vetr to Strong-Buy
www.americanbankingnews.com - March 20 at 12:22 AM |
Align Technology (NASDAQ:ALGN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Align Technology (NASDAQ:ALGN) Income Statement, Balance Sheet and Cash Flow Statement
Align Technology (NASDAQ ALGN) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
